Loading provider…
Loading provider…
Pulmonary Disease Physician in Charleston, SC
NPI: 1013011899Primary Practice Location
MUSC MEDICAL CENTER
25 Courtenay Dr, Charleston, SC
Primary Employer
MUSC University Hospital
muschealth.org
HQ Phone
Get MD Patrick's Phone Numberphone_androidMobile
Get MD Patrick's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardSC State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 101 | 119 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 94 | 117 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 29 | 29 |
Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary Exacerbations.
Authors: Don Sanders, Jerry Nick, Raksha Jain, Elliott Dasenbrook
Publication Date: 2016-09-30
Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure.
Authors: Doreen Addrizzo-Harris, Richard Wallace, Kevin Winthrop, David Griffith, Timothy Aksamit, Kevin Mange
Publication Date: 2020-12-22
Role of hyperglycemia in cystic fibrosis pulmonary exacerbations.
Authors: Margaret Rosenfeld, Andrea Kelly, Aniket Sidhaye, Phuong Vu, Lina Merjaneh
Journal: J Cyst Fibros
Publication Date: 2023-06-30
Lead Sponsor: Corbus Pharmaceuticals Inc.
Collaborators: Cystic Fibrosis Foundation
Intervention / Treatment: OTHER: Placebo, DRUG: Lenabasum 20 mg, DRUG: Lenabasum 5 mg
Lead Sponsor: Paratek Pharmaceuticals Inc
Intervention / Treatment: DRUG: Placebo, DRUG: Omadacycline Oral Tablet
Lead Sponsor: Armata Pharmaceuticals, Inc.
Collaborators: Cystic Fibrosis Foundation
Intervention / Treatment: OTHER: Placebo, BIOLOGICAL: AP-PA02